Dr. Morgan Hunter is an Investment Manager at BiomedVC, a Swiss venture capital firm investing in early-stage therapeutics across Europe. Prior to joining BiomedVC in 2022, Morgan initiated and developed the business case for planned ETH Zurich spin-off Emuna Therapeutics, leading an Innosuisse Innovation Project and as an SNF BRIDGE Proof of Concept Fellow. He holds a Doctor of Sciences in Pharmaceutical Immunology from ETH Zurich.